In cirrhotic patients variceal bleeding is more frequent in the evening and correlates with severity of liver disease

Hepato-Gastroenterology

Volumn 46, Issue 25, 1999, Pages 391-394

  Mann, N S ^a,b   Hillis, A ^a   Mann, S K ^a   Buerk, C A ^a   Prasad, V M ^a  

^a TEXAS A AND M UNIVERSITY   (United States)

^b (1116) VA Medical Center   (United States)

Author keywords

Cirrhosis; Evening shift; Portal hypertension; UGI bleeding

Indexed keywords

ADULT; AGED; ARTICLE; CIRCADIAN RHYTHM; CONTROLLED STUDY; DISEASE SEVERITY; ESOPHAGUS VARICES; FEMALE; GASTROINTESTINAL ENDOSCOPY; HEMATEMESIS; HUMAN; LIVER CIRRHOSIS; LIVER DISEASE; MAJOR CLINICAL STUDY; MALE; MELENA; PORTAL HYPERTENSION; PRIORITY JOURNAL; STOMACH DISEASE; STOMACH VARICES;

ADULT; AGED; AGED, 80 AND OVER; CIRCADIAN RHYTHM; ESOPHAGEAL AND GASTRIC VARICES; FEMALE; GASTROINTESTINAL HEMORRHAGE; HEMATEMESIS; HUMANS; LIVER CIRRHOSIS; MALE; MELENA; MIDDLE AGED; PORTAL PRESSURE; SEVERITY OF ILLNESS INDEX;

EID: 0033063735     PISSN: 01726390     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (35)

1. 1 Garcia-Pagan JC, Feu F, Castells A, et al: Circadian variation of portal pressure and variccal hemorrhage in patients with cirrhosis. Hepatol 1994; 19:595-601.
2. 2 Alvarez D, Golombeck D, Viola L, et al: Circadian portal blood flow patterns in patients with cirrhosis and portal hypertension. Gastroenterol 1992; 102:A774.
3. 3 Willich SN, Levy D, Rocco MB, et al: Circadian variation in the incidence of sudden cardiac death in the Framingham heart study population. Am J Cardiol 1987; 60:801-806.
4. 4 Panza JA, Epstein SE, Quyyumi AA: Circadian variations in vascular tone and its relation to sympathetic vasoconstrictor activity. N Engl J Med 1991; 325:986-990.
5. 5 Muller JE, Tofler GH, Stone PH: Circadian variations and triggers of onset of acute cardiovascular events, Circulation 1989; 79:733-743.
6. 6 Bergonzi P, Bianco A, Mcnnuni G, et al: Night sleep organization in patients with severe hepatic failure: Its modification after L-Dopa treatment. Eur Neurol 1978; 17:271-275.
7. 7 Bernardi M, Trevisani F, DePalma R, et al: Chronobiological evaluation of sympatho-adrenergic function in cirrhosis. Relationship with arterial pressure and heart rate. Gastroenterol 1987; 93:1178-1186.
8. 8 Zee P, Mehta R, Turek F, et al: Porto-caval anastomosis disrupts circadian locomotor activity and pineal melatonin rhythms in rats. Brain Res 1991; 560:17-22.
9. 9 Coy DL, Mehta R, Zee P, et al: Portal-systemic shunting and the disruption of circadian locomotor activity in the rat. Gastroenterol 1992; 103:222-228.
10. 10 Colantonio D, Pasqualetti P, Casale R, et al: Atrial natriuretic peptide-renin-aldosterone system in cirrhosis of the liver: Circadian study. Life-Sci 1989; 45:631-635.
11. 11 Trevisani F, Bernardi M, De Palma R, et al: Circadian variation in renal sodium and potassium handling in cirrhosis. The role of aldosterone, cortisol, sympatho-adrenergic tone and intra lobular factors. Gastroenterol 1989; 96:1187-1198.
12. 12 Hutchinson R, Moynihan BGA: Hunger pain and duodenal ulcer. Br Med J 1909; 1:926-927.
13. 13 Moore JG, Englert E: Circadian rhythm of gastric acid secretion in man. Nature 1970; 226:1261-1262.
14. 14 Larsen KR, Moore JG, Dayton MT: Circadian rhythms of gastric mucus efflux and residual mucus gel in the fasting rat stomach. Dig Dis Sci 1991; 36:1550-1555.
15. 15 Rigas B, Torosis J, McDougall CJ, et al: The circadian rhythm of biliary colic. J Clin Gastroenterol 1990; 12:409-414.
16. 16 Minoli G, Imperiale G, Spinzi GC, et al: Circadian periodicity and other clinical features of biliary pain. J Clin Gastroenterol 1991; 13:546-548.
17. 17 Bosch J, Navasa M, Garcia-Pagan JC, et al: Portal hypertension. Med Clin North Am 1989; 73:931-953.
18. 18 Henriksen JH, Staun-Olsen P, Fahrenberg J, et al: Vasoactive intestinal polypeptide in cirrhosis: Arteriovenous extraction in different vascular beds. Scand J Gastroenterol 1980; 15:787-792.
19. 19 Bendsten F, Schiffer S, Henriksen J: Increased Calcitonin gene-related peptide (CGRP) in cirrhosis J Hepatol 1991; 12:118-123.
20. 20 Jorde R, Burhol PG: Diurnal profile of gastrointestinal regulatory peptides. Scand J Gastroenterol 1985; 20:1-4.
21. 21 Trasforini G, Margutti A, Portaluppi F, et al: Circadian profile of plasma calcilonin gene-related peptide in healthy man. J Clin Endocrinol Metab 1991; 73:945-951.
22. 22 Linsell CR, Lightman SL, Mullen PE, et al: Circadian rhythms of epinephrine and norepinephrine in man. J Clin Endocrinol Metab 1985; 60:1210-1215.
23. 23 Vallance P, Moncada S: Hyperdynamic circulation in cirrhosis: a role for nitric oxide? Lancet 1991; 337:776-777.
24. 24 Ardent J: Melatonin. Clin Endocrinol 1988; 19:205-209.
25. 25 Redman J, Armstrong SM, Ng KT: Free-running activity rhythms in the rat: entrainment by melatonin. Science 1983; 219:1089-1091.
26. 26 Ralph MR, Manker M: Effect of diazepine on circadian phase advances and delays. Brain Res 1986; 372:405-408.
27. 27 Turek FW, Van Reeth O: Altering the mammalian circadian clock with short-acting benzodiazepine, triazolam. Trends Neuro Sci 1988; 11:535-541.
28. 28 Golombek DA, Escolar E, Huron L, et al: Chronopharmacology of melatonin: inhibition by benzodiazepine antagonist. Chrono Biol Int 1992; 9:124-131.
29. 29 Basile AS, Jones EA, Skolnick P: The pathogenesis and treatment of hepatic encephalopathy: evidence for the involvement of benzodiazepine receptor ligands. Pharmacol Rev 1991; 43:27-71.
30. 30 Siringo S, Di Febo G, Bolondi L, et al: Circadian occurrence of variceal bleeding in cirrhotics. Gastroenterol 1992; 102:A890.
31. 31 Merican I, Sprengers D, McCormick PA, et al: Diurnal pattern of variceal bleeding in cirrhotic patients. J Hepatol 1993; 19:15-22.
32. 32 Garcia-Pagen JC, Feu F, Bosch J, et al: Propranolol compared with propranolol plus isosorbide-5-mononitrate for portal hypertension in cirrhosis: a randomized controlled study. Ann Intern Med 1991; 114:869-873.
33. 33 Pagliaro L, Burroughs AK, Sorensen TIA, et al: Therapeutic controversies and randomized controlled trials: prevention of bleeding and rebleeding in cirrhosis. Gastroenterol Int 1989; 2:71-84.
34. 34 Poynard T, Cales P, Pasta L, et al: Bela-adrenergic-antagonist drugs in the prevention of gastrointestinal bleeding in patients with cirrhosis and esophageal varices: an analysis of data and prognostic factors in 589 patients from four randomized clinical trials. N Engl J Med 1991; 324:1532-1538.
35. 35 Groszmann RJ, Bosch J, Grace ND, et al: Hemodynamic events in a prospective randomized trial of propranolol Vs placebo in the prevention of the first variceal hemorrhage. Gastroenterol 1990; 99:1401-1407.